gene therapy

Asia

Pharma

Generic tariffs, Samsung Bio, HK IPO—Fierce Pharma Asia

President Trump unveiled generic drug tariffs. Samsung Bio will buy PolyPepide for $1.8 billion. A U.S. biotech seeks an IPO first in Hong Kong.

Angus Liu Jul 24, 2026 9:00am

Trust in block letters

Bayer diagnoses how to build trust in cell and gene therapies

May 6, 2026 10:45am

Roche

Roche to launch another Elevidys study, eying EU approval

Apr 16, 2026 10:06am

launch button

Rocket is priming a limited launch of its 1st gene therapy nod

Mar 27, 2026 10:25am

shortages drugs

CSL's Hemgenix in 'temporary global stockout,' company says

Mar 19, 2026 4:35pm

sarepta building

Sarepta CEO to retire, citing 'shocking and ironic twist of fate'

Feb 26, 2026 11:30am